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Abstract
The role of steroids in carcinogenesis has become a major concern in environmental protection, biomonitoring,
and clinical research. Although historically oestrogen has been related to development of reproductive system,
research over the last decade has confirmed its crucial role in the development and homeostasis of other organ
systems. As a number of anthropogenic agents are xenoestrogens, environmental health research has focused on
oestrogen receptor level disturbances and of aromatase polymorphisms. Oestrogen and xenoestrogens mediate
critical points in carcinogenesis by binding to oestrogen receptors, whose distribution is age-, gender-, and tissue-
specific. This review brings data about cancer types whose eatiology may be found in environmental exposure to
xenoestrogens. Cancer types that have been well documented in literature to be related with environmental
exposure include the reproductive system, breast, lung, kidney, pancreas, and brain. The results of our data mining
show (a) a significant correlation between exposure to xenoestrogens and increased, gender-related, cancer risk
and (b) a need to re-evaluate agents so far defined as endocrine disruptors, as they are also key molecules in
carcinogenesis. This revision may be used to further research of cancer aetiology and to improvement of related
legislation. Investigation of cancers caused by xenoestrogens may elucidate yet unknown mechanisms also
valuable for oncology and the development of new therapies.
Background
Despite the considerable efforts to decrease environmental
pollution we still witness uncontrolled introduction of
new compounds in living and working environment. Addi-
tionally, pollution control in low income and developing
countries has seen limited success. The balance between
needs of a fast growing human population and technol-
ogy/science development is questionable, partially as a
consequence that the available knowledge is not always
applied in an efficient way as it should be.
The last century’s paradigm “one agent - one disease”
has helped to identify the major causal pathways and
the identification of pollution related diseases, including
cancer. Based on this approach, epidemiological studies
set off many activities to reduce pollution and prevent
exposure. However, a large body of data accumulated
over the last decade, with a recent significant contribu-
tion of molecular biology, clearly shows that this histori-
cal simplistic interpretation of biomonitoring data fails
to answer a number of questions about environmental
threats to human health.
Cancer incidence monitoring in developed countries is
relatively accurate. A better classification of cancer types,
the networking of cancer registries, and the increasing
population coverage for cancer registration are unfortu-
nately accompanied, due to unsolved technical and organi-
zational difficulties, by publishing of cancer register
reports with a lag of several years. This lag is a serious
obstacle in identifying current environmental health risks
and setting timely effective preventive measures.
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any medium, provided the original work is properly cited.According to recent data [1], childhood cancer incidence
increases 1% a year all over Europe. In the adult popula-
tion a rising trend is reported for soft tissue sarcoma,
brain tumours, germ-cell tumours, lymphomas, renal
cancers, leukemias, breast cancer, and lung cancer in
women. Breast, colorectal, prostate, and lung cancer are
the most commonly diagnosed cancers in the European
population [2]. Only limited part of the detected increase
may be related to screening programs.
During the last decade, environmental health and oncol-
ogy have shown an increasing interest in oestrogen as an
evolutionary conserved molecule. With its endocrine,
paracrine, and neurotransmitting activity [3-5], oestrogen
is not limited to the development and regulation of the
reproductive system. The distribution of oestrogen recep-
tors in mammalian tissues suggests that oestrogens could
have a significant role in orchestrating a number of path-
ways in living organisms during development and adult-
hood. Additionally, new evidences confirm a strong
impact of this molecule on carcinogenesis [6-9].
Very little is known about changes in oestrogen levels
and the tissue ratio between alpha and beta oestrogen
receptors (ER) during development [10]. In the second tri-
mester of human foetal development the highest concen-
trations of ER beta mRNA are found in the testis and the
ovary and of ER alpha mRNA in the uterus. Relatively
high concentrations of either receptor are also present in
the spleen, while low levels are detected in the kidney, thy-
mus, skin, and lung [11]. The pre-pubertal ratio between
ERs alpha and beta in human tissues in males and females
is not known. Additionally, ER alpha and beta are poly-
morphically distributed and as such they play different
roles in carcinogenesis [12-14].
At higher levels, oestrogen is carcinogenic [15]; similar
to ionizing radiation it may produce reactive oxygen
species and cause hypomethylation and microsatellite
instability [9,16-18]. Its metabolites, quinones, cause the
formation of DNA adducts, depurination, lipid-derived
aldehyde-DNA adducts, and aneuploidy [15,19]. By
decreasing glutathione-S-transferases, oestrogens may
increase cellular oxidative DNA damage in oestrogen-
responsive tissues, when the organism is simultaneously
exposed to genotoxicants. This is an early step in the
process of carcinogenesis [20].
Gender differences in the incidence of cancers such as
the lung, kidney, or pancreas cancer suggest that hor-
mones may play a role in their aetiology [21]. Recent find-
ings suggest that all neoplastic mammalian tissues are
characterized by disturbances in ER levels [6]. As gender
related estrogen levels in foetal, and prepubertal tissues,
the tissue specific ER distribution and oestrogen bimodal
activity modulate the development of biological pathways
and organogenesis [22,23] some cancer types may have
origin in their prenatal and postnatal disturbance caused
by exposure to xenoestrogens.
The general population is exposed to a number of hor-
monally active compounds on a daily basis. These com-
pounds were introduced in the living environment during
the last few decades, the majority of which are xenoestro-
gens. Chemicals like polycyclic aromatic hydrocarbons
(PAH), pesticides, polychlorinated biphenyl (PCB),
dichlorodiphenyl-trichlorethane (DDT), some drugs (e.g.,
antiepileptic drugs), fungicides, cotinine, phytoestrogens,
mycotoxins, bisphenol A (a plastics additive), phthalates,
alkylphenols, and metalloestrogens mimic oestrogen
action, affect oestrogen levels, or bind to oestrogen recep-
tors [24-29]. Xenoestrogens are present in a number of
substrates such as cigarette smoke, automobile exhaust,
chemical industry pollutants, grilled meat, volcano dust,
forest fire smoke, milk, water, and cosmetic products. This
means that all human population may be exposed to them.
This article seeks to give an insight in how environmen-
tal exposure to xenoestrogens relates to breast, lung, kid-
ney, brain, pancreas, and reproductive system cancers,
which are all characterized by disturbances in ER.
Breast cancer
The reports on decrease of breast cancer incidence in
women 50-69 years old are related to improvement of
preventive measurements such as mammography
screening in developed countries. In the United States,
Australia, and Western Europe this decrease seems to
follow a decrease in hormonal therapy [30], as oestrogen
plays important role in pathogenesis of breast cancer
[31,32].
Factors involved in the development of breast cancer
incidence include the socioeconomic status, some food
additives, pesticides, oestrogen and progesterone replace-
ment therapy, some antibiotics, radiation, mutations at
genes BRCA1, BRCA2, metabolizing enzyme polymorph-
isms, epidermal growth factor and its receptor (HER),
androgen levels, and insulin-like growth factor [33-35].
Age (including transplacental, prepubertal) may also play
an important role in oestrogen exposure-related breast
cancer risk that probably involves epigenetic mechanisms
[36-39].
C u r r e n t l yt h e r ea r es o m e1 6 0x e n o e s t r o g e n st h a tm a y
be involved in breast cancer development [40-42].
Women are the largest consumers of cosmetic products
which may be a significant source of xenoestrogens.
Some, such as metalloestrogens (e.g., aluminium salts),
parabens, cyclosiloxanes, triclosan, UV screeners, phtha-
lates, Aloe Vera extracts, and musk are present in
numerous cosmetics products. Humans are exposed to
these chemicals transcutaneously and measurable levels
have been detected in human breast tissue [23].
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cancer development as even low alcohol consumption
increases serum oestradiol (especially for carriers of a
certain alcohol dehydrogenase allele) and stimulates ER
alpha [43,44]. On animal model it is shown that alcohol
increases oestradiol levels in dams, which leads to higher
levels of ER alpha receptors in their offspring mammary
gland and may launch tumorigenesis [37].
The effect of diet on breast cancer development was
observed in Japanese womena f t e rt h eS e c o n dW o r l d
War when dramatic changes in their diet happened
such as increased consumption of meat, eggs, and milk
containing oestrogens or oestrogen-like compounds
[45]. Milk is a source of oestrogen due to the practice of
milking pregnant cows [46].
Heterocyclic amine and their metabolites, especially 2-
amino-1-methyl6-phenylimidazo (4,5-b) pyridine (PhIP) is
present in high concentrations in well-cooked meat and it
binds to and activates the breast cell ER alpha [47,48]. In
animal model, it causes breast cancers [49]. The suggested
mechanisms of PhIP mechanisms are formation of PhIP-
DNA adducts and increase of proliferation in mammary
gland terminals and buds [50]. Similarly, at concentrations
higher than 140 μg/m3 polyaromatic hydrocarbons from
f o o dm a yi n c r e a s eb r e a s tc a n cer risk in postmenopausal
women if they were exposed to it early in life [51].
Styrene, a widely used plastic for food packing, has been
associated with breast cancer risk both in men and
women [52]. Direct intake of styrene is via food packed or
even cooked in styrene boxes with a direct migration of
styrene to food. Styrene and its metabolites bind to ER
alpha [53], cross the placental barrier, and also affect the
development of reproductive organs [54,55].
The carcinogenic potential of xenoestrogens may also
depend on polymorphism of metabolic enzymes. It is
shown that subpopulation carrying a polymorphism of
metabolic enzyme CYP1A1 m2 is more susceptible to
breast cancer development after exposure to polychlori-
nated biphenyls (PCB), which may explain contradictory
epidemiological reports on the association between breast
cancer incidence and PCB exposure [35,56,57].
Lung cancer
Lung cancer is the predominant cause of cancer mortality
[58]).There is a gender difference in the incidence of lung
cancer types. The leading cause in men is the squamous
cell carcinoma, and in women adenocarcinoma. Oestrogen
and ER distribution could be the main cause of this differ-
ence [59,60]. Despite the fact that lung cancer incidence is
increasing in women [61-64] studies reporting lung cancer
incidence basically rarely give attention to possibly gender
related susceptibility [65-67]. Lung cancer is about 70% ER
beta positive. The ratio between ER alpha and ER beta in
the lung tissue seems to be relevant for lung cancer
development and may explain the higher incidence of lung
adenocarcinoma in women than in men [68]. Increased
lung cancer risk in women is associated with a lower social
status and high level of indoor pollution with PCBs during
cooking as a consequence of coal usage [69,70]. ER beta
levels in lung cancer are gender related and have impact
on survival rate [71]. While ER beta receptor positive or
negative lung cancers has no impact on survival in
women, in men ER beta positive lung cancer is associated
with a significantly lower mortality than ER beta negative
lung cancer [72]. ER alpha modulates lung differentiation
and maturation while ER -beta causes proliferation of lung
cancer cells [73,74]. Gender specific distribution of CYP19
(aromatase) in lung cells puts in correlation oestrogen
levels and lung cancer etiology [75]. Additionally, women
taking oestrogen therapy have shown increased lung can-
cer incidence [76]. Same as for breast cancer epidermal
growth factor and its receptor HER plays a significant role
in non-small cell carcinoma and is associated with endo-
genous estrogen exposure [77].
Smoking remains the major cause of lung cancer in
humans [78]. Methylnitrosamino-pyridyl-butanone, a
powerful carcinogenic agent contained in cigarette
smoke is ER beta receptor related [69]. The activity of
nicotine is gender-specific [79], since cotinine, a nicotine
metabolite, is an aromatase inhibitor [80] that decreases
oestrogen end increases testosterone levels. Polonium
210 in cigarettes [81] may have similar activity as other
metalloestrogens [24,82]. Other carcinogens in cigarette
smoke should be re-evaluated for their xenoestrogen or
aromatase inhibitor potency.
Traffic air pollution is also related to lung cancer
[83,84]. A number of compounds from traffic emissions
are oestrogen ligand active compounds [85]. PAHs
represent one of the major mixtures of agents that are
present in polluted air have been demonstrated to affect
oestrogen homeostasis [86-88].
Industrial emissions also contain pollutants with oestro-
gen-like activity, such as heavy metals and dioxins [89]. A
significant association between industrial air pollutants
and lung cancer risk has been reported in women [90].
Arsenic is a known lung carcinogen [6] whose biological
effects include increased ER alpha transcription. In ani-
mals, transplacental exposure to arsenic causes lung
cancer in female offspring. This suggests that arsenic can
modify genes during foetal development which may cause
lung cancer later in life [91]. Figure 1 shows complex
environmental exposures which may lead to the lung
carcinogenesis.
Kidney cancer
Data on the environmental aetiology of kidney cancer
are not available, and much more research is needed.
The fact that renal cell carcinoma, the most common
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oestrogens [92] in animal model suggests the involve-
ment of oestrogen receptors in the aetiology of kidney
cancer and of a possible role of xenoestrogens. Kidney
cancer incidence seems to be gender -related, with an
incidence that is two times higher in men than in
women [93]. In addition, genetic polymorphisms of ER
alpha in the kidney seem to play a significant role in the
development of kidney cancer [92]. Cadmium and
arsenic as xenoestrogens may also induce kidney cancer
[94,95]
Pancreatic cancer
Understanding of pancreatic cancer aetiology is crucial,
as it is the fourth leading cause of cancer deaths in the
USA [64] and one of the most aggressive diseases. The
incidence of pancreatic cancer has been relatively stable
worldwide over the last few decades [96-98]. It is more
frequent in men than in women [99,100]. Pancreatic can-
cer cells are ER alpha and beta positive and consequently
may be modulated by oestrogen [101] which is consistent
with similar mechanisms observed in xenoestrogen-
related cancers [102,103]. There are very few data on the
effects of xenoestrogens on pancreatic cancer incidence.
Methylnitrosamino-pyridyl-butanone is the only com-
pound demonstrated to cause pancreatic cancer in ani-
mal models [104]. This finding has also been reported
for the adenocarcinoma of the lung and has been related
to ER beta activation [68].
It is also known that consumers of fried meat run a
higher risk of pancreatic cancer development probably
due to exposure to benzo(a)pyrene and other food con-
taminants that have xenoestrogenic properties [45,105].
Brain tumour
Brain tumours are characterized by disturbances in ERs
[106-108]. Transplacental exposure to xenoestrogens
may increase the risk of brain tumour development
[79,80]. Xenobiotics that inhibit aromatase also inhibit
the conversion of oestrogen to testosterone and may
have a significant impact on brain pathology, given the
evidence that disturbed levels of testosterone have impact
Figure 1 Schematic presentation of lung cancer development
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brain cancer incidence has been reported in humans liv-
ing near petrochemical industries [110]. Despite the fact
that the exact chemical composition of the mixture of air
pollutants remains unknown, polycyclic aromatic hydro-
carbons (PAH) are present in polluted air in such areas
[ 6 7 ] .P A H sa sx e n o e s t r o g e n - l i k ea g e n t s[ 8 7 ]m a yh a v e
played a causal role on the excess of brain cancer inci-
dence detected
Reproductive system
Testicular cancer incidence has significantly increased
over the last few decades with yet no clear hypothesis
on impact of environment on its aetiology [111]. As this
trend cannot be explained by cryptorchidism, smoking,
genetic variations, or physiological stress, the role of
environmental exposure is being investigated to eluci-
date its aetiology and to identify preventive measures
[112].
Both ER alpha and beta are expressed in the human
testis and are involved in the control of testicular func-
tion [113]. The role played by xenoestrogens on testis
development is still only partly known in the animal
model, with results showing very dynamic changes in
tissue sensitivity to xenoestrogens with unknown conse-
quences during puberty and adulthood [114].
There are a limited number of studies reporting possi-
ble association between testicular cancer and distur-
bances in oestrogen levels. Testicular cancer has been
reported in sons of smoking mothers [115], but also in
mothers who were taking antiepileptics during pregnancy
[116]. Both antiepileptics and cotinine from cigarette
smoke are aromatase inhibitors. Transplacental exposure
to aromatase inhibitors and consequently increased levels
of testosterone may have long-term effects in humans, as
shown in an animal model [117].
Epidemiological studies also suggest increased risk of
testicular cancer following prenatal exposure to oestrogens
[118].
Styrene storage containers may contaminate food which
becomes a source of styrene exposure. Transplacental
exposure to low levels of styrene may lead to the disturbed
development of male genital organ [54]. However, its
effect on cancer development remains unknown.
Endocrine disrupting chemicals which disturb ERs can
cause female reproductive dysfunction [119,120]. As
ovarian cancer therapy is still not marked with significant
success and mortality is very high it is of major signifi-
cance elucidation of its aetiology [121].
Cadmium, one of most investigated heavy metals, has a
significant role on ovarian and reproductive functions, as
it lowers progesterone levels and mimics oestrogen in
various tissues by binding to ER alpha. Cadmium is not
confined to occupational exposure alone; it is found in
cigarette smoke, food, nickel/cadmium batteries, pig-
ments, and plastics [122].
Ovarian cancer is associated with milk and cheese
consumption due to oestrogen and insulin growth factor
present in milk of pregnant cows [46,123].
According to recent experimental evidence, uranium
in water should be further considered in research as an
additional risk for reproductive cancers [82].
Conclusions
As an evolutionary conserved molecule, oestrogen is
present in both plants and animals. Oestrogen is recog-
nized today as a critical modulator of development,
homeostasis in adulthood and orchestration of response
to environment.
Although gene polymorphisms can change cancer inci-
dence [124,125], it is clear that environment has predo-
minance over genes in cancer risk. Responses to
environmental stressors are age- and gender related, and
transplacental exposure to xenoestrogens has been
shown to have long-term effects in experimental models,
as it modulates hormonal response in puberty This
means that exposure to endocrine agents not only poses
a health risk during exposure, but also increases suscept-
ibility later in life [114,126,127]. Differences in suscept-
ibility to xenoestrogens may be related to steroid and
xenobiotic receptor levels, which are high in young adults
(15-38y old) and decrease with age [128].
Current estimates of cancer risk in humans do not
account properly for transplacental and environmental
(including occupational) exposure to xenoestrogens. The
role of xenoestrogens in cancer development should be
re-evaluated using a new approach that would reflect
the complexity of carcinogenesis.
Reductionism as the main scientific philosophy of the
20
th century gave a significant input to environmental
health. However, the quantity of data available in noo-
sphere, systems biology as a tool and new softwares for
data sharing enable the investigation of interactions
between xenoestrogens and other environmental stres-
sors, such as radiation, and add new dimensions to the
research of cancer aetiology using complexity as a new
scientific philosophy. Contemporary mathematical mod-
els and systems biology allows the incorporation of all
available data and modeling cancer risk allowing free
interaction and clustering of data.
The collaboration of environmental health with oncol-
ogy would be of crucial significance in the study of
xenoestrogens as estrogen has today significant position in
oncological diagnostics and therapy what includes mea-
surements of ER levels in different tissues. Clinical oncol-
ogy today takes part in scientific projects in order to
achieve optimal treatment at the individual level (tailored
therapy) and produces large amounts of data that reflect a
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gender specific susceptibility. Collaboration between phar-
macokineticians, oncologists, histopathologists, molecular
epidemiologists, and genotoxicologists may improve our
knowledge of cancer aetiology and lead to gender specific
and final individualized therapies.
Available information systems and building of integrated
exposure-disease pathways will give policymakers much
more useful input in future for more efficient regulations
than a large number of agent- and disease-specific studies.
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